Nasdaq Launches New Quality Assurance Platform, Nasdaq Validator
NEW YORK, 2016-04-26 13:00 CEST (GLOBE NEWSWIRE) -- Nasdaq(Nasdaq:NDAQ), has officially launched the Nasdaq Validator to support exchanges, clearinghouses and central securities depositories (CSDs) in reducing the cost and complexity of quality assurance (QA), and bring new functionality to market quickly and effectively. Nasdaq Validator is an API-independent testing platform offering manual and automated test tools for the capital markets industry that was created from Nasdaq’s experience in developing and delivering marketplace systems to over 100 exchange clients worldwide.
The solution focuses on shortening time-to-market for manual tests, driving efficiencies in the testing and QA process and simplifying access and usage of test tools enabling a broader user group, particularly those less technologically-oriented, to be engaged in the verification process. Nasdaq Validator interfaces with Nasdaq’s matching, clearing and CSD systems, in addition to systems by other providers; it is currently in-use by Nasdaq and external clients.
“Delivering new functionality and offerings to the market as swiftly as possible can greatly differentiate marketplaces in a competitive environment,” said Lars Ottersgård, Executive Vice President and Head of Market Technology, Nasdaq. “Equally as important is being able to deliver this new functionality safely and efficiently, which requires rigorous, robust testing and quality assurance programs. This becomes very costly from a financial and human capital perspective due to implementation sophistication and the level of technical resources required to carry out the functions. By offering Nasdaq Validator to marketplaces worldwide, we are squarely addressing the absolute necessity for robust QA processes, while reducing expenditures and shortening the go-to-market timetable.”
The Nasdaq Validator will support clients through the following benefits:
- Accelerating development and deployment of trading, clearing and CSD system components, decreasing overall time-to-market for enhancements and adaptations;
- Empowering all users working across the development lifecycle to test as they go, as no programming or scripting language is necessary to utilize the platform;
- Reducing cost and complexity enabling usage of a single platform that supports concurrent testing of multiple protocols, sessions in one graphical user interface;
Nasdaq’s exchange technology, including trading, clearing, CSD and market surveillance systems, is in operation in over 100 marketplaces across the USA, Europe, Asia, Australia, Africa and the Middle East.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.6 trillion and nearly 10,000 corporate clients. To learn more, visit:nasdaq.com/ambitionorbusiness.nasdaq.com.
For Media Inquiries:
Direct: +44 (0) 20 3753 2231
Mobile: +44 (0) 7809 596 390
New technology solution is built to accelerate time-to-market with robust testing and unparalleled quality assurance
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Crown Bioscience Inc.23.11.2017 14:01 | pressemeddelelse
Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose Monitoring
Bermuda Business Development Agency (BDA)23.11.2017 06:26 | pressemeddelelse
BDA partners with government to attract cryptocurrency
VistaJet Ltd22.11.2017 11:40 | pressemeddelelse
VistaJet Partners With Christie's for the Global Tour of The Collection of Peggy and David Rockefeller
Nasdaq22.11.2017 10:03 | pressemeddelelse
Nasdaq to Deliver Blockchain e-Voting Solution to Strate
Oxford Immunotec21.11.2017 15:16 | pressemeddelelse
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference
Crown Bioscience Inc.21.11.2017 14:02 | pressemeddelelse
CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum